-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HqD3Nl1BTseBXQ9pIWSSlLlpFVB8oqpngIA7TrRgCH0Dk65vz2LVZXOkHN3yLjcy CVn/mSrIMkj1npPuuJYoag== 0000891836-02-000216.txt : 20020430 0000891836-02-000216.hdr.sgml : 20020430 ACCESSION NUMBER: 0000891836-02-000216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020409 FILED AS OF DATE: 20020430 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MIRAVANT MEDICAL TECHNOLOGIES CENTRAL INDEX KEY: 0000933745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770222872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25544 FILM NUMBER: 02626006 BUSINESS ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 BUSINESS PHONE: 8056859880 MAIL ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 FORMER COMPANY: FORMER CONFORMED NAME: PDT INC /DE/ DATE OF NAME CHANGE: 19941214 COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] OWNER IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 4 1 sc0102-02.txt FORM 4 :----------: :----------------------------: : FORM 4 : : OMB APPROVAL : :----------: :----------------------------: :OMB NUMBER 3235-0287 : :EXPIRES: JANUARY 31, 2005 : :ESTIMATED AVERAGE BURDEN : :HOURS PER RESPONSE..... 1.0 : :----------------------------: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [X] CHECK THIS BOX IF NO LONGER SUBJECT TO SECTION 16. FORM 4 OR FORM 5 OBLIGATIONS MAY CONTINUE. SEE INSTRUCTION 1(b). ================================================================================ 1. Name and Address of Reporting Person* Pharmacia Corporation ----------------------------------------------------------------------------- (Last) (First) (Middle) 100 Route 206 North ----------------------------------------------------------------------------- (Street) Peapack, New Jersey 07977 ----------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name AND Ticker or Trading Symbol Miravant Medical Technologies ("MRVT") ----------------------------------------------------------------------------- ================================================================================ 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) ----------------------------------------------------------------------------- ================================================================================ 4. Statement for Month/Year 4/02 ----------------------------------------------------------------------------- ================================================================================ 5. If Amendment, Date of Original (Month/Year) ----------------------------------------------------------------------------- ================================================================================ 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X 10% Owner _____ Officer (give title below) ____ Other (Specify below) ----------------------------------------------------------------------------- ================================================================================ 7. Individual or Joint/Group Filing (Check applicable Line) X Form filed by One Reporting Person __ Form Filed by More than One Reporting Person ================================================================================ TABLE I-NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) action action or Disposed of (D) Securities Bene- Form: Direct Indirect Date Code (Instr. 3, 4 and 5) ficially Owned (D) or Beneficial (Month/ (Instr. 8) ------------------------ at End of Indirect (I) Ownership Day/ ------------ Amount (A) or Price Month (Instr. (Instr. 4) (Instr. 4) Year) Code V (D) 3 and 4) - ------------------- --------- ------------ ------------------------ ------------------ -------------- --------------- Common Stock, par 4/4/02 S 521,900 D 1.418885 1,339,634 I FN1 value $0.01 per Share - ------------------------------------------------------------------------------------------------------------------------------------ *If the form is filed by more than one reporting person, see Instruction 4(b)(v). (Over) POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQURIED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
FORM 4 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) 1. Title of Derivative Security (Instr. 3) --------------------------------------------------------------------------- ================================================================================ 2. Conversion or Exercise Price of Derivative Security --------------------------------------------------------------------------- ================================================================================ 3. Transaction Date (Month/Date/Year) --------------------------------------------------------------------------- ================================================================================ 4. Transaction Code (Instr. 8) Code V ------------------ ------------ ================================================================================ 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) (A) (D) ------------------ ------------ ================================================================================ 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable Expiration Date ------------------------ ------------------------ ================================================================================ 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title Amount or Number of Shares ------------------ -------------------------- ================================================================================ 8. Price of Derivative Security (Instr. 5) ================================================================================ 9. Number of Derivative Securities Beneficially Owned at End of Month (Instr. 4) --------------------------------------------------------------------------- ================================================================================ 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) --------------------------------------------------------------------------- ================================================================================ 11. Nature of Indirect Beneficial Ownership (Instr. 4) --------------------------------------------------------------------------- ================================================================================ Explanation of Responses: FN1 Shares sold were held directly by Pharmacia Italia S.p.A., a wholly owned subsidiary of Pharmacia Corporation. By: PHARMACIA CORPORATION /s/ Don W. Schmitz April 9, 2002 --------------------------------------- --------------- **Signature of Reporting Person Date Name: Don W. Schmitz Title: Corporate Secretary ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 of 2 pages -----END PRIVACY-ENHANCED MESSAGE-----